Ftse Mib
38.592,81
-0,48%
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
82.605,96
-4,12%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Biodexa Pharmaceuticals PLC (BDRX) Biodexa Pharmaceuticals PLC (BDRX) Notizie

Biodexa Pharmaceuticals PLC

BDRX
3,12
0,01 (0,32%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202514:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/3/202514:30GLOBEBiodexa Announces Appointment of Precision for Medicine LLC..
24/2/202514:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/2/202514:30GLOBEBiodexa Announces Allowance of U.S. Patent Covering Oral..
18/2/202522:30EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
13/2/202514:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/2/202514:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/2/202514:30GLOBEBiodexa Receives US FDA Fast Track Designation for eRapa in..
28/1/202512:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/1/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
22/1/202514:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/1/202514:30GLOBEBiodexa Strengthens Management Team - Appointment of Dr Gary..
21/1/202512:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/1/202512:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/1/202512:24EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/1/202512:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/1/202512:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/1/202512:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/1/202512:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/1/202522:49EDGAR2Form F-1 - Registration statement for certain foreign..
17/1/202522:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202512:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/202512:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/202512:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/202512:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/202512:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/202512:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/202512:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/12/202423:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/12/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202414:30GLOBEResult of General Meeting
12/11/202422:30EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/11/202422:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/11/202422:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/11/202414:48GLOBEBiodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ..
07/11/202422:51EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202422:30GLOBENotice of General Meeting
05/11/202412:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/11/202412:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/11/202412:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/11/202412:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/11/202412:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/11/202412:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/11/202422:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/10/202415:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/10/202415:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/10/202415:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/10/202415:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
Apertura: 3,11 Min: 2,90 Max: 3,11
Chiusura: 3,11

La tua Cronologia

NASDAQ
BDRX
Biodexa Pharmaceuticals
EU
0103N
Natixis Sa null
EU
FRSG00014ZE0
SG Issuer Sg Issuer Zc D...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci